Method of reducing nicotine and tobacco craving in mammals
Patent 6262049 Issued on July 17, 2001. Estimated Expiration Date: October 23, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
A method of reducing cravings in a mammal to nicotine or tobacco is disclosed. The method comprises administering to the mammal an effective amount of a D1 /D5 antagonist or a D1 /D5 partial agonist alone or in combination with other specified CNS compounds.
Other References
Panocka et al, Derwent Drug File Abstracts, abstract no. 1995-39814.
Ng et al, Medline Abstracts, abstract no. 95203333, 1994.
Dyr et al, Biological Abstracts, abstract no. 1993:323964.
Archer et al, Derwent Drug File Abstracts, abstract no. 1996-21249.
Caine et al, Derwent Drug File Abstracts, abstract no. 1994-38611.
Guse et al, Derwent Drug File Abstracts, abstract no. 1993-19338.
Cervo L., et al., Brain Research 673:2 pp. 242-250 (Mar. 6, 1995)
Bednar, et al., American J. of Physiology 269:4 pt. 2 R896-902 (Oct., 1995)
Cervo, et al., Brain Research 731:31-38 (1996)
Nielsen, et al., European Journal of Pharmacology, 11:167-176 (1985)
Corrigall, et al., Pharmacology Biochemistry and Behavior, 48:3 pp. 817-820 (1994)
W. Dry, et al., "Effects of D1 and D2 Dopamine Receptor Agents on Ethanol Consumption in the High-Alcohol-Drinking (HAD) Line of Rats," Alcohol, 10:207-212 (1993)
Samochowiec et al., Pharmazie 50 pp. 815-818 (1995)
I. Panocka et al., "Effects of the dopamine D1 receptor antagonist SCH 39166 on the ingestive behaviour of alcohol-preferring rats," Psychopharmacology 120:227-235 (1995)
Gordon YK. Ng, et al., "Dopamine receptor agonist reduces ethanol self-administration in the ethanol-preferring C57BL/6J inbred mouse," European Journal of Pharmacology, Section 269 pp. 365-374 (1994)
Sydney Archer, et al., Suppression of Morphine and cocaine Self-Administration in Rats by Mixed Mu Antagonist-Kappa Agonist (N-CBM-TAMO) and a Long-Acting Selective D1 Antagonist (AS0300), Bioorganic & Medicinal Chemistry Letters 6:10 pp. 1139-1144 (1996)
S. Barak Caine, et al., "Effects of Dopamine D-1 and D-2 Antagonists on Cocaine Self-Administration Under Different Schedules of Reinforcement in the Rat," The Journal of Pharmacology and Experimental Therapeutics, 270:1 pp. 209-218, 1994
Paul A. Guse, et al., "Attentuation of Arrhythmogenic Effects of Cocaine by a Dopaminergic Antagonist Schering 39166," JACC 21:2 Feb. 1993, Abstrac
October 23, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
